Literature DB >> 30283986

Posterior circulation involvement and collateral flow pattern in moyamoya disease with the RNF213 polymorphism.

Won-Hyung Kim1, Sang-Dae Kim2, Myung-Hyun Nam3, Jin-Man Jung4, Sung-Won Jin1, Sung-Kon Ha1, Dong-Jun Lim1, Hae-Bin Lee1.   

Abstract

PURPOSE: Moyamoya disease is a chronic cerebrovascular disorder characterized by progressive stenosis of the circle of Willis with a compensatory collateral vessel network. Recent studies have identified the ring finger protein 213 gene (RNF213) as the unique susceptibility gene for moyamoya disease. The purpose of this study was to compare clinical features of moyamoya disease, especially angiographic findings, between patients with and without the RNF213 mutation.
METHODS: Blood samples from 35 patients with moyamoya disease were obtained between May 2016 and May 2017. Information on age at the time of diagnosis, sex, and initial symptom were obtained via retrospective chart review. Angiographic records were evaluated.
RESULTS: RNF213 variants were detected in the 28 of 35 patients (80%), including all pediatric patients (100%) and 18 of 25 adult patients (72%) in our cohort. Leptomeningeal collateral flow from posterior to anterior circulation was more frequent in the RNF213-negative group than in the RNF213-positive group (100% versus 38.9%; p = 0.020). Posterior cerebral arterial territorial involvement was more frequently observed in RNF213-positive patients than in RNF213-negative patients (50% versus 0%; p = 0.027).
CONCLUSIONS: RNF213 may play a significant role in the development of collateral anastomoses.

Entities:  

Keywords:  Cerebrovascular disorder; Collateral anastomoses; Moyamoya disease; RNF213

Year:  2018        PMID: 30283986     DOI: 10.1007/s00381-018-3985-5

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  28 in total

1.  A genome-wide association study identifies RNF213 as the first Moyamoya disease gene.

Authors:  Fumiaki Kamada; Yoko Aoki; Ayumi Narisawa; Yu Abe; Shoko Komatsuzaki; Atsuo Kikuchi; Junko Kanno; Tetsuya Niihori; Masao Ono; Naoto Ishii; Yuji Owada; Miki Fujimura; Yoichi Mashimo; Yoichi Suzuki; Akira Hata; Shigeru Tsuchiya; Teiji Tominaga; Yoichi Matsubara; Shigeo Kure
Journal:  J Hum Genet       Date:  2010-11-04       Impact factor: 3.172

2.  Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan.

Authors:  M Fukui
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

3.  Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.

Authors:  Eun-Hee Kim; Mi-Sun Yum; Young-Shin Ra; Jun Bum Park; Jae Sung Ahn; Gu-Hwan Kim; Hyun Woo Goo; Tae-Sung Ko; Han-Wook Yoo
Journal:  J Neurosurg       Date:  2015-10-02       Impact factor: 5.115

4.  Clinical and radiographic features of moyamoya disease in patients with both cerebral ischaemia and haemorrhage.

Authors:  Tomohito Hishikawa; Koji Tokunaga; Kenji Sugiu; Isao Date
Journal:  Br J Neurosurg       Date:  2012-08-30       Impact factor: 1.596

5.  Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations.

Authors:  Wanyang Liu; Toshiaki Hitomi; Hatasu Kobayashi; Kouji H Harada; Akio Koizumi
Journal:  Neurol Med Chir (Tokyo)       Date:  2012       Impact factor: 1.742

6.  Changing ischaemic lesion patterns in adult moyamoya disease.

Authors:  J-M Kim; S-H Lee; J-K Roh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-05-01       Impact factor: 10.154

7.  Treatment of moyamoya disease with STA-MCA anastomosis.

Authors:  J Karasawa; H Kikuchi; S Furuse; J Kawamura; T Sakaki
Journal:  J Neurosurg       Date:  1978-11       Impact factor: 5.115

8.  Posterior circulation in moyamoya disease: angiographic study.

Authors:  I Yamada; Y Himeno; S Suzuki; Y Matsushima
Journal:  Radiology       Date:  1995-10       Impact factor: 11.105

9.  Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.

Authors:  Wanyang Liu; Daisuke Morito; Seiji Takashima; Yohei Mineharu; Hatasu Kobayashi; Toshiaki Hitomi; Hirokuni Hashikata; Norio Matsuura; Satoru Yamazaki; Atsushi Toyoda; Ken-ichiro Kikuta; Yasushi Takagi; Kouji H Harada; Asao Fujiyama; Roman Herzig; Boris Krischek; Liping Zou; Jeong Eun Kim; Masafumi Kitakaze; Susumu Miyamoto; Kazuhiro Nagata; Nobuo Hashimoto; Akio Koizumi
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

Review 10.  Genetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as a Susceptibility Gene.

Authors:  Miki Fujimura; Shinya Sonobe; Yasuo Nishijima; Kuniyasu Niizuma; Hiroyuki Sakata; Shigeo Kure; Teiji Tominaga
Journal:  J Stroke       Date:  2014-05-30       Impact factor: 6.967

View more
  6 in total

1.  RNF213 p.Arg4810Lys Heterozygosity in Moyamoya Disease Indicates Early Onset and Bilateral Cerebrovascular Events.

Authors:  Daiichiro Ishigami; Satoru Miyawaki; Hideaki Imai; Masahiro Shimizu; Hiroki Hongo; Shogo Dofuku; Kenta Ohara; Yu Teranishi; Daisuke Shimada; Satoshi Koizumi; Hideaki Ono; Yudai Hirano; Masafumi Segawa; Hirofumi Nakatomi; Nobuhito Saito
Journal:  Transl Stroke Res       Date:  2021-10-30       Impact factor: 6.829

2.  A rare case of pediatric moyamoya disease with reversible white matter lesions in a 3-year-old Chinese girl.

Authors:  Shi-Jun Li; Jie Xiong; Yu He; Yang-Yang Xiao; Ding-An Mao; Li-Qun Liu
Journal:  Childs Nerv Syst       Date:  2019-11-10       Impact factor: 1.475

3.  Angiographic study of the transdural collaterals at the anterior cranial fossa in patients with Moyamoya disease.

Authors:  Kun Hou; Guichen Li; Yunbao Guo; Baofeng Xu; Kan Xu; Jinlu Yu
Journal:  Int J Med Sci       Date:  2020-07-25       Impact factor: 3.738

4.  Predictive role of heterozygous p.R4810K of RNF213 in the phenotype of Chinese moyamoya disease.

Authors:  Yue Wang; Zhengshan Zhang; Ling Wei; Qian Zhang; Zhengxing Zou; Luping Yang; Desheng Li; Mengke Shang; Cong Han; Michael Mambiya; Xiangyang Bao; Qian Li; Fangbin Hao; Kaili Zhang; Hui Wang; Shan Liu; Mengwei Liu; Fanxin Zeng; Fangfang Nie; Kai Wang; Wanyang Liu; Lian Duan
Journal:  Neurology       Date:  2020-01-16       Impact factor: 9.910

Review 5.  The Genetic Basis of Moyamoya Disease.

Authors:  R Mertens; M Graupera; H Gerhardt; A Bersano; E Tournier-Lasserve; M A Mensah; S Mundlos; P Vajkoczy
Journal:  Transl Stroke Res       Date:  2021-09-16       Impact factor: 6.829

6.  The angiographic presentation of European Moyamoya angiopathy.

Authors:  Sara Pilgram-Pastor; René Chapot; Markus Kraemer
Journal:  J Neurol       Date:  2021-07-08       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.